SEC Form 4 · accession 0001104659-19-004459
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Michael Cashman
Officer — CEO · Director
Period of report
Jan 28, 2019
Accepted (ET)
Jan 30, 2019 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jan 28, 2019 | S | 8,142 | $3.13 | D | 239,761 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the sale of common stock in order to satisfy tax withholding obligations upon vesting of restricted stock.